The Best Groundbreaking research in Torrance, California

The Lundquist Institute, located at 1124 West Carson Street in Torrance, California, is a renowned biomedical research institution dedicated to advancing scientific discoveries and improving healthcare outcomes. With a focus on translational research, the institute collaborates with leading scientists and clinicians to accelerate the development of innovative treatments and therapies for a wide range of diseases. The state-of-the-art facilities and cutting-edge technology at The Lundquist Institute ensure that researchers have the resources they need to make groundbreaking discoveries that have a real impact on patient care.

Harbor UCLA Pediatrics, located at 21840 Normandie Avenue in Torrance, California, is a renowned institution affiliated with the David Geffen School of Medicine at UCLA. As a Los Angeles County hospital, Harbor-UCLA Medical Center offers exceptional pediatric care and instruction by a dedicated team of academic faculty. The Department of Pediatrics at Harbor-UCLA is committed to providing cutting-edge research opportunities for both faculty and residents, supported by industry grants and partnerships with high-profile organizations. Affiliated with the Lundquist Institute for Biomedical Research, Harbor-UCLA Pediatrics combines top-notch scientific research with state-of-the-art clinical care. With a focus on training the next generation of pediatric leaders in a diverse environment, Harbor-UCLA is dedicated to preparing physicians for the challenges and opportunities in the ever-evolving field of medicine. From community activism to groundbreaking research, Harbor-UCLA Pediatrics is proud of the contributions its faculty and graduates have made to improve children's health.

BioLabs at The Lundquist Institute is a cutting-edge research facility located at 1124 West Carson Street in Torrance, California. This state-of-the-art institution provides scientists and entrepreneurs with the resources and support they need to advance their work in the fields of biotechnology and life sciences. With top-of-the-line equipment, expert staff, and a collaborative environment, BioLabs at The Lundquist Institute is a hub for innovation and discovery. Researchers have access to shared lab spaces, office amenities, and networking opportunities, making it the ideal place to bring groundbreaking ideas to life.

Dr. Nerses Tchekmedyian is a renowned doctor specializing in oncology located at 3640 Lomita Boulevard in Torrance, California. With over 40 years of experience, Dr. Tchekmedyian has personally treated over 15,000 patients and has conducted groundbreaking research that has improved cancer treatment and patient well-being. His philosophy revolves around providing comprehensive care for his patients and ensuring that he follows up and follows through on their treatment. Dr. Tchekmedyian's scientific achievements include being the first to publish on quality of life in oncology, discovering the appetite-enhancing effects of megestrol acetate, and conducting the first-in-human clinical study of the CTLA4 antibody, which revolutionized immunotherapy in oncology. He is an active member of the Early Therapeutics Research Team at City of Hope. Dr. Tchekmedyian earned his medical degree from the University of Medicine in Montevideo, Uruguay, and completed his residency and fellowship in internal medicine, oncology, and hematology in New York and Maryland. He values the trust and gratitude of his patients as his most significant professional recognitions.

Dr. Guy Young is a renowned institution located at 3440 Torrance Boulevard, Torrance, California, United States. Specializing in pediatric hematology/oncology, Dr. Guy Young completed his medical training at prestigious institutions such as Schneider Children's Hospital-Long Island Jewish Medical Center and Children's National Medical Center in Washington, DC. With a focus on state-of-the-art therapies for children with bleeding or clotting disorders, the institution conducts groundbreaking research in areas such as hemophilia and thrombosis. Dr. Guy Young's team is dedicated to improving the management of patients with hemophilia and thrombosis by testing novel therapies and assessing patient responses. Through collaborations with industry partners, the institution is testing new compounds to enhance patient outcomes in hemophilia. Additionally, they are evaluating drugs approved for adult use for their safety and efficacy in pediatric patients with thrombosis.